Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
PRESS RELEASES
VYNE Therapeutics Added To Nasdaq Biotechnology Index
By GlobeNewswire
Dec 16, 2020 8:00 AM EST
PRESS RELEASES
VYNE Therapeutics To Present At The 32nd Annual Piper Sandler Healthcare Conference
By GlobeNewswire
Nov 25, 2020 8:00 AM EST
PRESS RELEASES
VYNE Therapeutics Announces Covered Status For ZILXI™ (minocycline) With Express Scripts
By PR Newswire
Oct 7, 2020 8:01 AM EDT
PRESS RELEASES
VYNE Therapeutics To Host Physician Symposium On AMZEEQ® And ZILXI™
By GlobeNewswire
Sep 23, 2020 8:00 AM EDT
PRESS RELEASES
VYNE Therapeutics Announces The Appointment Of Patrick G. LePore To Its Board Of Directors
By GlobeNewswire
Sep 14, 2020 8:00 AM EDT
PRESS RELEASES
Menlo Therapeutics Announces Completion Of Corporate Name Change To VYNE Therapeutics
By PR Newswire
Sep 8, 2020 8:01 AM EDT
